Institutional & Family Asset Management’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-11
Closed -$3K 927
2020
Q4
$3K Hold
11
﹤0.01% 689
2020
Q3
$3K Hold
11
﹤0.01% 632
2020
Q2
$2K Sell
11
-3
-21% -$560 ﹤0.01% 671
2020
Q1
$3K Buy
14
+4
+40% +$712 ﹤0.01% 578
2019
Q4
$2K Hold
10
﹤0.01% 702
2019
Q3
$1K Sell
10
-1
-9% -$130 ﹤0.01% 762
2019
Q2
$1K Buy
+11
New +$1.3K ﹤0.01% 779

Other funds holding AMED

Institutional & Family Asset Management's AMED Position: Q1 2021 in Review

Institutional & Family Asset Management sold out of Amedisys (AMED) in Q1 2021, closing a stake of 11 shares — an estimated $3K sold.

Institutional & Family Asset Management first reported a position in AMED in Q2 2019 and held it in 7 quarters. The position peaked at $3K in Q4 2020. 388 funds tracked by Wall St. Rank hold AMED as of Q1 2021.

  • Institutional & Family Asset Management reported no remaining Amedisys position as of Q1 2021 after selling out during the quarter.
  • Institutional & Family Asset Management sold 11 Amedisys shares in Q1 2021, an estimated $3K.
  • Institutional & Family Asset Management first reported a position in Amedisys in Q2 2019 and held it in 7 quarters.
  • Institutional & Family Asset Management's Amedisys position peaked at $3K in Q4 2020.
  • 388 funds tracked by Wall St. Rank held Amedisys as of Q1 2021.

Based on Institutional & Family Asset Management's 13F filing for Q1 2021, filed 6 May 2021.